Form D · Biotechnology

CELL GENESYS INC

South San Francisco, CA · CIK 0000865231

Offering snapshot reported Apr 17, 2009 · SEC filing

Reported sold
$310K
Offering amount: $310K
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 17, 2009Initial$310,000No comparisonNot reportedSEC filing
Feb 20, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Feb 20, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-86523-1L

Source: Form D, filed Apr 17, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Marc L Belsky Executive
David W Carter Director
Nancy M Crowell Director
James M Gower Director
John T Potts, Jr. Director
Thomas E Shenk Director
Stephen A Sherwin Director, Executive
Eugene L Step Director
Sharon E Tetlow Executive
Robert H. Tidwell Executive
Inder M Verma Director
Dennis L Winger Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
400 Oyster Point Boulevard Suite 525
South San Francisco, CA, 94080